ResearcherMashhad University of Medical SciencesNo recent work listed

Fereshteh Asgharzadeh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8349-3722; OpenAlex author ID A5048547583. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper

Papers 1

Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic Cancer. Co-author DOI 10.2174/1568009622666220517104411 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Amir Avan · 1 shared paper, 2022 · strength 0.17
- Paper Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancrea… DOI 10.2174/1568009622666220517104411 ↗
Gordon A. Ferns · 1 shared paper, 2022 · strength 0.17
- Paper Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancrea… DOI 10.2174/1568009622666220517104411 ↗
Majid Khazaei · 1 shared paper, 2022 · strength 0.17
- Paper Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancrea… DOI 10.2174/1568009622666220517104411 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.